Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
9/30/2025 | $ -241.36M | -28.91% | $ 834.95M |
6/30/2025 | $ -225.79M | -22.41% | $ 1.01B |
3/31/2025 | $ -201.59M | -28.56% | $ 705.94M |
12/31/2024 | $ -181.86M | -12.25% | $ 1.48B |
9/30/2024 | $ -106.9M | -6.39% | $ 1.67B |
6/30/2024 | $ -105.97M | -7.47% | $ 1.42B |
3/31/2024 | $ -83.87M | -10.88% | $ 771.18M |
12/31/2023 | $ -89.77M | -18.64% | $ 481.61M |
9/30/2023 | $ -154.39M | -51.09% | $ 302.18M |
6/30/2023 | $ -160.52M | -33.04% | $ 485.86M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for NURIX THERAPEUTICS INC is calculated as follows: FCF [ $ -4.63M ] / Market Cap [ $ 1.55B ]
(=) FCF Yield [ -0.3% ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.58% |
median | 3.21% |
std | 11.38% |